Search by Drug Name or NDC

    NDC 00009-0107-04 Lincocin 300 mg/mL Details

    Lincocin 300 mg/mL

    Lincocin is a INTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Pharmacia & Upjohn Company LLC. The primary component is LINCOMYCIN HYDROCHLORIDE.

    Product Information

    NDC 00009-0107
    Product ID 0009-0107_fb3f510e-c1a6-40b9-9543-e10bf7142065
    Associated GPIs
    GCN Sequence Number 009338
    GCN Sequence Number Description lincomycin HCl VIAL 300 MG/ML INJECTION
    HIC3 W1K
    HIC3 Description LINCOSAMIDE ANTIBIOTICS
    GCN 40810
    HICL Sequence Number 004043
    HICL Sequence Number Description LINCOMYCIN HCL
    Brand/Generic Brand
    Proprietary Name Lincocin
    Proprietary Name Suffix n/a
    Non-Proprietary Name lincomycin hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL
    Active Ingredient Strength 300
    Active Ingredient Units mg/mL
    Substance Name LINCOMYCIN HYDROCHLORIDE
    Labeler Name Pharmacia & Upjohn Company LLC
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA050317
    Listing Certified Through 2024-12-31

    Package

    NDC 00009-0107-04 (00009010704)

    NDC Package Code 0009-0107-04
    Billing NDC 00009010704
    Package 1 VIAL in 1 CARTON (0009-0107-04) / 10 mL in 1 VIAL
    Marketing Start Date 2023-04-18
    NDC Exclude Flag N
    Pricing Information N/A